Schneider F, Kanitz E, Gerrard D E, Kuhn G, Brüssow K P, Nürnberg K, Fiedler I, Nürnberg G, Ender K, Rehfeldt C
Division of Reproductive Biology, Research Institute for the Biology of Farm Animals, Wilhelm-Stahl-Allee 2, 18196 Dummerstorf, Germany.
Domest Anim Endocrinol. 2002 Nov;23(4):455-74. doi: 10.1016/s0739-7240(02)00175-3.
The objective of this study was to examine the effects of somatotropin (ST) on porcine reproductive and metabolic statuses during early pregnancy. Four pregnant crossbred gilts received 6 mg of recombinant porcine somatotropin (rpST) daily from days 10 to 27 after artificial insemination while six pregnant gilts served as controls. Blood samples were taken on days 8, 10, 12, 14, 18, 22, and 27 prior to rpST injections (8:00 h) and subsequently at 9:00, 10:00, 12:00, 14:00, 16:00, 18:00, and 20:00 h. On all remaining days of treatment, samples were taken once daily before injections (8:00 h). The samples were assayed for the metabolic hormones: ST, insulin-like growth factor I (IGF-I), insulin, thyroxine (T(4)), triiodothyronine (T(3)), and cortisol; for metabolites: free fatty acids (FFA) and glucose; and for the reproductive hormones: luteinizing hormone (LH), progesterone, estradiol-17beta, estrone sulfate, and prostaglandin F(2alpha). Delivery of rpST daily induced a 20- to 40-fold increase in plasma ST concentrations. Moreover, repeated administration of rpST resulted in a continuous increase in plasma IGF-I concentration (P < 0.001), from 191.0 +/- 22.3-340.0 +/- 15.3 ng/mL 24 h after initial injection to 591.3 +/- 46.8 ng/mL after final injections. Mean serum insulin tended to be greater in rpST-treated gilts. Blood concentrations of T(4) were reduced (P < 0.05) from day 14 of gestation in treated gilts while T(3) concentrations remained unchanged. Concentrations of both glucose and FFA were greater (P < 0.01) and cortisol concentrations were unchanged in treated gilts. Changes in reproductive steroid hormones were minimally affected. Circulating progesterone (P = 0.078), and estradiol-17beta (P = 0.087) concentrations tended to be lower in treated animals. These data show that treatment of pregnant gilts with rpST during early gestation mainly impacts metabolic rather than reproductive status.
本研究的目的是检测生长激素(ST)对妊娠早期母猪生殖和代谢状态的影响。4头怀孕的杂种母猪在人工授精后第10天至27天每天接受6毫克重组猪生长激素(rpST),6头怀孕母猪作为对照。在注射rpST前(8:00)的第8、10、12、14、18、22和27天采集血样,随后在9:00、10:00、12:00、14:00、16:00、18:00和20:00采集。在治疗的所有剩余天数,每天在注射前(8:00)采集一次样本。对样本进行代谢激素检测:ST、胰岛素样生长因子I(IGF-I)、胰岛素、甲状腺素(T4)、三碘甲状腺原氨酸(T3)和皮质醇;代谢物检测:游离脂肪酸(FFA)和葡萄糖;生殖激素检测:促黄体生成素(LH)、孕酮、雌二醇-17β、硫酸雌酮和前列腺素F2α。每天注射rpST导致血浆ST浓度增加20至40倍。此外,重复注射rpST导致血浆IGF-I浓度持续升高(P<0.001),从首次注射后24小时的191.0±22.3纳克/毫升升至末次注射后的591.3±46.8纳克/毫升。rpST处理的母猪平均血清胰岛素水平趋于升高。治疗组母猪从妊娠第14天起血中T4浓度降低(P<0.05),而T3浓度保持不变。治疗组母猪的葡萄糖和FFA浓度均升高(P<0.01),皮质醇浓度不变。生殖类固醇激素的变化受到的影响最小。治疗组动物循环孕酮(P=0.078)和雌二醇-17β(P=0.087)浓度趋于降低。这些数据表明,妊娠早期用rpST治疗怀孕母猪主要影响代谢状态而非生殖状态。